138 related articles for article (PubMed ID: 30676102)
1. Trending gabapentin exposures in Kentucky after legislation requiring use of the state prescription drug monitoring program for all opioid prescriptions
Faryar KA; Webb AN; Bhandari B; Price TG; Bosse GM
Clin Toxicol (Phila); 2019 Jun; 57(6):398-403. PubMed ID: 30676102
[TBL] [Abstract][Full Text] [Related]
2. Trends in gabapentin and baclofen exposures reported to U.S. poison centers.
Reynolds K; Kaufman R; Korenoski A; Fennimore L; Shulman J; Lynch M
Clin Toxicol (Phila); 2020 Jul; 58(7):763-772. PubMed ID: 31786961
[No Abstract] [Full Text] [Related]
3. The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.
Liang D; Shi Y
Drug Alcohol Depend; 2020 Jan; 206():107754. PubMed ID: 31786399
[TBL] [Abstract][Full Text] [Related]
4. Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).
Agrawal R; Verma S; Halappanavar M
Community Ment Health J; 2021 Jul; 57(5):920-925. PubMed ID: 32666418
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices.
Hargrove SL; Bunn TL; Slavova S; Quesinberry D; Corey T; Ralston W; Singleton MD; Ingram V
Inj Prev; 2018 Feb; 24(1):60-67. PubMed ID: 28739777
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
[TBL] [Abstract][Full Text] [Related]
7. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
8. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
9. Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data.
Friedrich JM; Sun C; Geng X; Calello DP; Gillam M; Medeiros KL; Smith M; Ruck B; Mazer-Amirshahi M
Clin Toxicol (Phila); 2020 Jul; 58(7):725-731. PubMed ID: 31612741
[No Abstract] [Full Text] [Related]
10. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
Phillips E; Gazmararian J
J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
[TBL] [Abstract][Full Text] [Related]
11. 2017 Annual Report of the University of Kansas Health System Poison Control Center.
Oller LK; Coons DM; Thornton SL
Kans J Med; 2019 Aug; 12(3):70-79. PubMed ID: 31489103
[TBL] [Abstract][Full Text] [Related]
12. Opioid analgesics and heroin: Examining drug misuse trends among a sample of drug treatment clients in Kentucky.
Victor GA; Walker R; Cole J; Logan TK
Int J Drug Policy; 2017 Aug; 46():1-6. PubMed ID: 28511053
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of poison center services in a state-wide overdose education and naloxone distribution program.
Doyon S; Benton C; Anderson BA; Baier M; Haas E; Hadley L; Maehr J; Rebbert-Franklin K; Olsen Y; Welsh C
Am J Addict; 2016 Jun; 25(4):301-6. PubMed ID: 27219823
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of gabapentin in drug overdose postmortem toxicology testing results.
Slavova S; Miller A; Bunn TL; White JR; Kirschke D; Light T; Christy D; Thompson G; Winecker R
Drug Alcohol Depend; 2018 May; 186():80-85. PubMed ID: 29554591
[TBL] [Abstract][Full Text] [Related]
15. Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008-2013.
Pelissier F; de Haro L; Cardona F; Picot C; Puskarczyk E; Sapori JM; Tournoud C; Franchitto N
Clin Toxicol (Phila); 2017 Apr; 55(4):275-284. PubMed ID: 28152635
[TBL] [Abstract][Full Text] [Related]
16. 2016 Annual Report of the University of Kansas Health System Poison Control Center.
Thornton SL; Oller L; Coons DM
Kans J Med; 2018 May; 11(2):1-23. PubMed ID: 29796151
[TBL] [Abstract][Full Text] [Related]
17. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
Hughes AA; Bogdan GM; Dart RC
Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
[TBL] [Abstract][Full Text] [Related]
19. Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.
Thornton SL; Darracq MA
J Med Toxicol; 2020 Jan; 16(1):33-40. PubMed ID: 31410729
[TBL] [Abstract][Full Text] [Related]
20. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014.
Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC
Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
